These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16107719)

  • 1. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.
    Dawson JP; Berger MB; Lin CC; Schlessinger J; Lemmon MA; Ferguson KM
    Mol Cell Biol; 2005 Sep; 25(17):7734-42. PubMed ID: 16107719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-induced structural transitions in ErbB receptor extracellular domains.
    Dawson JP; Bu Z; Lemmon MA
    Structure; 2007 Aug; 15(8):942-54. PubMed ID: 17697999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the epidermal growth factor receptor: a series of twists and turns.
    Poger D; Mark AE
    Biochemistry; 2014 Apr; 53(16):2710-21. PubMed ID: 24697572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
    Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
    Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.
    Yu X; Sharma KD; Takahashi T; Iwamoto R; Mekada E
    Mol Biol Cell; 2002 Jul; 13(7):2547-57. PubMed ID: 12134089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
    Zhang X; Gureasko J; Shen K; Cole PA; Kuriyan J
    Cell; 2006 Jun; 125(6):1137-49. PubMed ID: 16777603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor.
    Bessman NJ; Bagchi A; Ferguson KM; Lemmon MA
    Cell Rep; 2014 Nov; 9(4):1306-17. PubMed ID: 25453753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR).
    Zhu L; Zhao L; Wu M; Chen Z; Li H
    Immunol Lett; 2013 Jun; 153(1-2):33-40. PubMed ID: 23871733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural perspective on the regulation of the epidermal growth factor receptor.
    Kovacs E; Zorn JA; Huang Y; Barros T; Kuriyan J
    Annu Rev Biochem; 2015; 84():739-64. PubMed ID: 25621509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand binding induces a conformational change in epidermal growth factor receptor dimers.
    Walker F; Rothacker J; Henderson C; Nice EC; Catimel B; Zhang HH; Scott AM; Bailey MF; Orchard SG; Adams TE; Liu Z; Garrett TP; Clayton AH; Burgess AW
    Growth Factors; 2012 Dec; 30(6):394-409. PubMed ID: 23163584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
    Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
    EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
    Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
    J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational regulation of the EGFR kinase core by the juxtamembrane and C-terminal tail: a molecular dynamics study.
    Mustafa M; Mirza A; Kannan N
    Proteins; 2011 Jan; 79(1):99-114. PubMed ID: 20938978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.
    Li S; Schmitz KR; Jeffrey PD; Wiltzius JJ; Kussie P; Ferguson KM
    Cancer Cell; 2005 Apr; 7(4):301-11. PubMed ID: 15837620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
    Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
    Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation.
    Papakyriakou A; Vourloumis D; Tzortzatou-Stathopoulou F; Karpusas M
    Proteins; 2009 Aug; 76(2):375-86. PubMed ID: 19173306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the extracellular region of HER3 reveals an interdomain tether.
    Cho HS; Leahy DJ
    Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transmembrane domains of ErbB receptors do not dimerize strongly in micelles.
    Stanley AM; Fleming KG
    J Mol Biol; 2005 Apr; 347(4):759-72. PubMed ID: 15769468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.